Immune‑related myocarditis due to combination use of nivolumab and ipilimumab

Wei Min, Xia Zongling

PDF(280 KB)
PDF(280 KB)
Adverse Drug Reactions Journal ›› 2020, Vol. 22 ›› Issue (9) : 527-528. DOI: 10.3760/cma.j.cn114015-20190513-00416

Immune‑related myocarditis due to combination use of nivolumab and ipilimumab

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 22(9): 527-528 https://doi.org/10.3760/cma.j.cn114015-20190513-00416

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(280 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉